-transparent.png){kind=logo}
A panel of anti-human antibodies was used in order to investigate their cross-reactivity with canine leukocytes. The labeling was carried out at the microscopic level by immunocytochemical staining. Of 50 antibodies 22 cross-reacted with canine leukocytes from afferent lymph and peripheral blood. All leukocytes reacted with MHM23 (CD18). Two anti-HLA DR antibodies, DK22 and L243, reacted mostly with veiled cells and with PHA-stimulated lymphocytes, whereas TAL1B5 was cross-reactive with all canine lymphocytes. The activation markers CD25, Ki-67, PCNA were identified on PHA-stimulated lymphocytes with ACT1, Ki-67 and PC10 clone produced antibodies. Canine eosinophils reacted with MHM6 (CD23) antibody. A large number of antibodies reacted with canine lymph veiled cells. Canine granulocytes and a subset of lymphocytes were stained with the anti-CD15 antibody only after treatment of cytospins with neuraminidase.
H Galkowska, and
L O Waldemar, and
U Wojewodzka
March 1994,
Tissue antigens,
H Galkowska, and
L O Waldemar, and
U Wojewodzka
July 1987,
Veterinary immunology and immunopathology,
H Galkowska, and
L O Waldemar, and
U Wojewodzka
May 1984,
Biology of reproduction,
H Galkowska, and
L O Waldemar, and
U Wojewodzka
February 1985,
Veterinary immunology and immunopathology,
H Galkowska, and
L O Waldemar, and
U Wojewodzka
January 1984,
Developments in biological standardization,
H Galkowska, and
L O Waldemar, and
U Wojewodzka
January 1987,
Advances in experimental medicine and biology,
H Galkowska, and
L O Waldemar, and
U Wojewodzka
December 1993,
Disease markers,
H Galkowska, and
L O Waldemar, and
U Wojewodzka
July 2015,
Stem cell research,
H Galkowska, and
L O Waldemar, and
U Wojewodzka
May 1986,
Cancer research,
H Galkowska, and
L O Waldemar, and
U Wojewodzka
January 1991,
Advances in immunology,
